: New Data On Safety And Efficacy In Type 2 Diabetes Patients With Renal Impairment<br />
<b>Deprecated</b>: urlencode(): Passing null to parameter #1 ($string) of type string is deprecated in <b>/var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php</b> on line <b>22</b><br />
)
Data presented at the American Diabetes Association (ADA) 73rd Scientific Sessions® provides insights for use of Trajenta® (linagliptin) in adults with Type 2 Diabetes (T2D) with moderate to severe renal impairment
Read more
Trajenta® (Linagliptin): New Data On Safety And Efficacy In Type 2 Diabetes Patients With Renal Impairment